Document is current
Any future updates will be listed below
-
Authors
Li, Li
Lopez Perez, Ramon
Shehzad, Khuram
Jennemann, Richard
Schmidt, Claudia
Walle, Thomas https://orcid.org/0000-0003-4835-955X
Tietz-Dahlfuß, Alexandra
Grimm, Elisabeth
Kraske, Joscha A. https://orcid.org/0000-0002-8567-6020
Häring, Peter
Barayeu, Uladzimir https://orcid.org/0000-0001-8426-166X
Dick, Tobias P.
Ye, Luxi
Braun, Stephan A.
Hertl, Michael
Worzfeld, Thomas
Wiech, Thorsten
Ji, Huihui
Su, Jing
Schneeweiss, Jonathan M. https://orcid.org/0009-0004-6934-7501
Liu, Muzi
Kommoss, Katharina https://orcid.org/0000-0003-2428-2658
Heikenwälder, Matthias
Zou, Bingwen https://orcid.org/0000-0002-0825-3657
Mücklich, Sabrina
Steinbrink, Kerstin
Raker, Verena K. https://orcid.org/0000-0001-7264-0371
Wu, Wenjun
Noessner, Elfriede
Gröne, Hermann-Josef
Nelson, Peter J.
Sandhoff, Roger https://orcid.org/0000-0003-3794-9458
Huber, Peter E. https://orcid.org/0000-0002-4811-300X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TR156 C06-246807620)
Deutsche Forschungsgemeinschaft (SFB/TR156 start-up grant)
Deutsche Forschungsgemeinschaft (SFB1009 B11-194468054)
Deutsche Forschungsgemeinschaft (TR156 A04/C05-246807620)
Deutsche Forschungsgemeinschaft (SFB1066 B06-213555243)
Deutsche Forschungsgemeinschaft (SFB1450 C06-431460824)
Deutsche Forschungsgemeinschaft (TR156 A04/C05-246807620)
Deutsche Forschungsgemeinschaft (TR156 C06-246807620)
China Scholarship Council (Research Grant)
Research grant from the Affiliated Hospital of Southwest Medical University, China
Deutsche Krebshilfe (Research Grant)
Deutsche Krebshilfe (Research Grant)
Physician-Scientist Program of Heidelberg University, Faculty of Medicine
Bundesministerium für Bildung und Forschung (BMBF/BMU: 03NUK004A,C)
- License Information
-
More Information
Article History
Received: 16 January 2025
Revised: 14 November 2025
Accepted: 16 December 2025
First Online: 2 February 2026
Competing interests
: The authors declare that they have no competing financial interests. TWA discloses research funding (not related to this study) from CanVirex AG, Basel, Switzerland; IKF Klinische Krebsforschung, Frankfurt, Germany; travel support from Roche; shareholding from Roche, Bayer, Innate Pharma, Illumina, Fibrogen, 10x Genomics, AstraZeneca, Merck KGaA, and BioNTech.
